kabutan

DAIICHI SANKYO COMPANY, LIMITED(4568) Summary

4568
TSE Prime
DAIICHI SANKYO COMPANY, LIMITED
2,867.0
JPY
+23.0
(+0.81%)
Mar 6, 3:30 pm JST
18.16
USD
Mar 6, 1:30 am EST
Result
PTS
outside of trading hours
2,825
Mar 6, 11:57 pm JST
Summary Chart Historical News Financial Result
PER
18.2
PBR
3.07
Yield
2.72%
Margin Trading Ratio
13.74
Stock Price
Mar 6, 2026
Opening Mar 6, 9:00 am
2,810.0 JPY 17.83 USD
Previous Close Mar 5
2,844.0 JPY 18.09 USD
High Mar 6, 1:05 pm
2,899.0 JPY 18.40 USD
Low Mar 6, 9:05 am
2,798.0 JPY 17.76 USD
Volume
5,900,700
Trading Value
0.02T JPY 0.11B USD
VWAP
2859.21 JPY 18.12 USD
Minimum Trading Value
286,700 JPY 1,816 USD
Market Cap
5.43T JPY 0.03T USD
Number of Trades
9,012
Liquidity & Number of Trades
As of Mar 6, 2026
Liquidity
High
1-Year Average
9,590
1-Year High Jan 30, 2026
50,451
Margin Trading
Date Short Interest Long Margin Positions Ratio
Feb 27, 2026 145,200 7,850,800 54.07
Feb 20, 2026 158,000 8,677,200 54.92
Feb 13, 2026 149,500 8,382,200 56.07
Feb 6, 2026 151,300 8,666,000 57.28
Jan 30, 2026 141,200 8,824,000 62.49
Company Profile
DAIICHI SANKYO COMPANY, LIMITED is a major pharmaceutical company in Japan, with strengths in cardiovascular and infectious diseases. The company has partnered with AstraZeneca of the UK for new cancer drugs.
Sector
Pharmaceuticals
DAIICHI SANKYO COMPANY, LIMITED primarily engages in the research, development, manufacturing, and sales of pharmaceuticals, with a broad range of operations both domestically and internationally. In Japan, the company operates through multiple subsidiaries involved in pharmaceutical manufacturing, research and development and sales of over-the-counter drugs, and vaccine research, development, and production, showcasing a diverse group of companies with varied functions. The company has partnered with AstraZeneca in the oncology field. Internationally, DAIICHI SANKYO has subsidiaries in the United States, Europe, China, Brazil, and other regions, conducting pharmaceutical research, development, manufacturing, and sales in each area. In the United States, the company has established a holding company, while in Europe, it operates through numerous group companies across various countries. DAIICHI SANKYO leverages its global network for research, development, manufacturing, and sales to enhance its competitiveness in the world market.